Introduction
The endocrine characteristics of normal human pregnancy have been difficult to establish, chiefly because spontaneous pregnancies occur unpredictably. More reliable sources of early pregnancy data are conceptions following various assisted reproductive technologies although, unfortunately, many of these may not be useful for determining normal physiology, firstly, because there is multiple follicle development resulting from the use of exogenous gonadotrophins and, secondly, because human chorionic gonadotrophin (hCG) given to induce luteinization masks hCG from the implanting embryo. Furthermore, the practice, at least for in-vitro fertilization (I VF), of replacing up to 3 embryos renders assessment of the number of implantation sites uncertain.
In-vitro fertilization in the natural or spontaneous cycle may provide a useful model in which to study early human implantation as only a single embryo is obtained and replaced. The intensive nature of IVF monitoring and treatment means that it is acceptable to continue intensive sur¬ veillance of the subject involved to detect early pregnancy. However, although not definitively established, it is commonly believed that procedures currently used for in-vitro fertilization are not ideal and indeed may be contributing to the uniformly low implantation rates per embryo (Rogers et ai, 1986) . Inadequate culture conditions may give rise to a higher incidence of pregnancy loss than following in-vivo conception (Osborn & Moor, 1988) although this is unlikely to be the sole factor involved in the genesis of pregnancy wastage in couples who are already infertile for one reason or another (Brambati, 1990 ). All of the existing studies on pregnancy loss following IVF relate to patients who have undergone ovarian stimulation in whom it is not possible to separate the potentially adverse effects of stimulation from those due to inadequate culture conditions (Smitz et ai, 1988;  Bongso, 1990; Tur-Kaspar et ai, 1990) .
The present study is observational and assesses pregnancy outcome in 2 groups of women. Firstly, a group of women who were being intensively monitored in menstrual cycles in which they conceived spontaneously, forming the in-vivo conception group and, secondly, a number of women who conceived following natural cycle IVF and constitute the in-vitro conception group. These in-vitro pregnancies could be a valuable source of early pregnancy data, provided they are not sig¬ nificantly different from in-vivo pregnancies. If, however, significant differences are observed, since ovarian stimulation has not been employed, the inference is that pregnancies obtained following in-vitro fertilization and culture are compromised relative to in-vivo conceptions.
In-vivo conception cycles
The in-vivo conception group consisted of 39 women who conceived during a cycle of inten¬ sive (daily or almost daily) blood sampling. Although 31 of these cycles were completely spontaneous (79%), a low dose of clomiphene citrate (50 mg/day for 5 days; Clomid: Merrell Div¬ ision, Richardson Merrell Ltd, Slough, Berkshire, UK) had been administered during the early follicular phase to 4 women and bromocriptine (2-5-5-0 mg/day; Parlodel: Sandoz Products Ltd, Feltham, Middlesex, UK) had been given to a further 4 women. Neither of these agents influenced the timing or onset of the luteinizing hormone (LH) surge, which was detected in all instances. The characteristics of a number of these spontaneous conceptions have been described elsewhere (Lenton et ai, 1982a; Lenton & Woodward, 1988 (Lenton et ai, 1988b (<2 h) although at the expense of sensitivity, which is only~1 U/l; but interassay coefficients of variation are good, at 6-7% at 25-6 U/l. To compare hCG profiles relative to a fixed point for in-vivo and in-vitro groups, the day of maximum early morning LH concentrations (LH surge) and the day of oocyte (egg) recovery are used interchangeably. In~85% of IVF cycles, egg recovery falls on the day of the LH surge and in the remaining 15% of cycles it takes place on the following morning. Although measurement of hCG in plasma or urine is not directly equivalent, the two profiles ( Fig. 1 Pregnancy is defined here as any cycle in which hCG is detected at a concentration that is > 5U/1. To avoid the attribution of a pregnancy to spurious or isolated positive hCG measurements, the definition requires that the first detected rise in hCG should occur at a time which is approximately physiological (i.e. after Day 7 and before Day 14 from the LH surge or egg recovery) and that hCG concentrations should rise for several days. Naturally hCG concentrations will continue to rise if the pregnancy is progressing normally, but will fall serially if the pregnancy becomes nonviable. This definition of pregnancy is somewhat more rigorous and is capable of detecting pregnancy earlier than those used by most other investigators (Liu et ai, 1988a; Acosta et ai, 1990) Chartier et ai, 1979) . Despite the absence of clinical corroboration of pregnancy, the definition of biochemical pregnancy employed here is specific, requiring full moni¬ toring of rising and falling hCG concentrations. In practice, it is possible to subdivide further the biochemical pregnancy group according to maximum hCG concentrations attained, e.g. hCG maximum between 40 and 150 U/l, 10 and 39 U/l or 5 and 9-9 U/l.
Since hCG concentrations rise exponentially following implantation ( Fig. 1) , it is clear that the highest hCG concentration will be attained in pregnancies which continue the longest. This point is important because it will influence whether and what kind of ultrasound evidence of pregnancy (gestation sac or foetal heart) is observed (Table 1) (Riddle et ai, 1988; Brambati, 1990) . Although attempts have been made to ascribe specific significance to the different 'grades' of pregnancy loss (e.g. anembryonic pregnancies), it is more likely that they represent different points on a continuous spectrum of early pregnancy loss. It is logical to assume that the most severely compromised preg¬ nancies will be lost sooner (so the highest hCG concentrations observed will be lower) than less severely compromised pregnancies. These differences may not be relevant to the individuals con¬ cerned, none of whom succeeds in delivering a baby, but are important to the evaluation of the efficiency of an assisted-reproduction programme. Cooke, 1988) , but only 64% of the in-vitro pregnancies, ended in delivery. These in-vitro conception rates are, of course, for natural cycle IVF but an equivalent figure of 63% deliveries per clinical pregnancy was obtained in two stimulated IVF programmes (Lenton et ai, 1988; Liu et ai, 1988b (Fig. 2a) and a clinical abortion after detection of a foetal heart (Fig. 2b) , hCG concentrations rose throughout the period of observation although marked discontinuity of the rise was evident (Fig. 2a) . The anembryonic loss was the more abnormal preg¬ nancy of the two (abortion occurred sooner, at 43 days, than in the second pregnancy (Fig. 2b) , where it occurred 76 days from egg recovery). In contrast, in the two normal pregnancies (Fig. 1) , hCG concentrations rose smoothly throughout the first 20 days.
In each of 2 biochemical pregnancies (Fig. 3) hCG concentrations rose steadily for several days before an apparent crisis after which concentrations declined (with a half-life of~40 h, the estab¬ lished decay time of hCG; Lenton et ai, 1988) . Menstrual bleeding in each case was evident 5 days after hCG started to decline and is probably secondary to falling progesterone concentrations, since, at this stage of pregnancy, the corpus luteum is dependent on continuing stimulation from the trophoblast (Lenton & Woodward, 1988) . Although the highest hCG concentrations were simi¬ lar in both these examples, there were differences in both the 'time of implantation' (first rise in hCG, on Day 13 (Fig. 3a) and on Day 9 (Fig. 3b) and in the rate of rise of hCG, which was faster in one pregnancy (Fig. 3b) than in the other (Fig. 3a) . The late implantation and slow hCG rise in the latter pregnancy suggest an embryo that was perhaps showing signs of abnormality even before implantation (Liu et ai, 1988b (Lenton et ai, 1988) . Kinetics of hCG concentrations in early pregnancy
The first increase in hCG is detected 9-13 days following the LH surge or egg recovery (Figs 1-3; Liu et ai, 1988b) and, thereafter, concentrations generally rise exponentially (Lenton & Woodward, 1988) . This increase may be smooth or, in some abnormal pregnancies, discontinuous (Fig. 2a) . The double exponential rise in hCG can be resolved into two straight lines ( Fig. 4a and b) : an initial phase with a rapid doubling time (slope or gradient) and a later slower phase. It is hypothe¬ sized that the faster component (A) is synchronous with the actual process of implantation and represents an early stage in foetal-maternal communication. The later slower component (B) is considered to represent a postimplantation event when equilibrium between trophoblastic hCG secretion and circulating maternal hCG concentrations has been established. By virtue of the straight-line appearance of these individual hCG profiles, calculation of both doubling times for each pregnancy is generally simple. A further characteristic of these profiles which is also amenable to mathematical description, is the interval between LH surge and egg recovery. First, an hCG concentration (which can be measured with confidence in all pregnancies in a series) is defined and the time (T) after LH surge or egg recovery when concentrations of this magnitude are observed is determined. In an earlier analysis of the in-vivo conception, 0-5 U/l hCG was used to define (Lenton & Woodward, 1988) . Unfortunately, the immunoenzymetric hCG assay used here for the in-vitro group was not sufficiently sensitive for this definition to be valid. Instead, an hCG concen¬ tration of 2 U/l was chosen to determine (see Fig. 4 ) for both groups and data for the in-vivo group were recalculated from the earlier study. Fig. 4) (4) 9-9 + 0-7(17) 10-5 ± 0-7 (7) 10-6 + 0-9 (8) 12-6 + 1-7(11) In-vivo and in-vitro biochemical pregnancies are signifi¬ cantly different (P < 002). Number of pregnancies indicated in parentheses.
The interval between the LH surge and hCG2.0U/, was 9-5 + 0-6 days for the in-vivo group (Table 4 ). In the earlier study (Lenton & Woodward, 1988) , the comparable LH surge to hCG05LI/| interval was 8-4 + 0-7 days. In that study, it was considered that the point hCG05U/, was slightly later than, but closely related to, the start of implantation. Thus, in the present study, the slightly longer interval (i.e. increase from a mean of 8-4 to 9-5 days) indicates that the time chosen here is a point which is linked to the start of implantation, but is, perhaps, some 24-48 h later. Other investigators have obtained similar results using different hCG concentration cut-offs, e.g. Fig. 4 ), there appears to be a trend for all in-vitro conceptions (Table 5) , whether destined to succeed or fail, to demonstrate slower peri¬ implantation doubling times than their equivalent in-vivo pregnancies. One explanation for this systematic difference could be a consequence of using two separate assays to measure hCG, but identity in (Table 4 ) and in the postimplantation doubling times (Table 5) does not support this supposition. Indeed, postimplantation doubling times were within the range reported by others for similar stages of in-vivo and in-vitro pregnancies (Liu et ai, 1988a; Kadar et ai, 1990) . Thus, although successful and unsuccessful in-vivo and in-vitro pregnancies were similar in the kinetics of their hCG profiles, there remains a suggestion that the in-vitro pregnancies were slightly comprised during their early, peri-implantation phase, although only the in-vitro biochemical pregnancies displayed more-variable implantation times.
Conclusions
Some pregnancy loss can be expected to follow natural conception (Wilmut, 1986) , but rates are considerably higher following in-vitro fertilization and culture whether this is performed after natural cycle egg recovery or ovarian stimulation. This effect could be due to less than ideal culture conditions (which are common to both these methods of IVF), but it is also likely to be a consequence of unidentified reproductive abnormalities amongst patients coming to IVF.
There are only small differences between the kinetics of hCG secretion in the in-vivo or in-vitro conceptions in these natural or unstimulated cycles. In-vitro biochemical pregnancies tend to implant later and more variably than in-vivo biochemical pregnancies but there are no differences in implantation times between other 'grades' of clinical pregnancy. This small difference in in-vitro biochemical pregnancies could be influenced by abnormalities in division or 'hatching', both of which could result from an unfavourable culture environment. Peri-implantation doubling times in the biochemical group were also the slowest, most of these pregnancies never achieved foetalmaternal equilibrium and it is probable that most never completed implantation. Apart from this, there was a tendency for all in-vitro conceptions to show slower peri-implantation hCG doubling than their in-vivo counterparts, regardless of outcome, again suggesting a subtle deleterious effect associated with IVF.
The present study demonstrates that, except in specific detail, in-vitro pregnancies in natural cycles are not different from in-vivo ones, although pregnancy wastage is clearly higher in women undergoing any sort of IVF and implantation rates per embryo are lower (Osborn & Moor, 1988) . Thus, while differences in pregnancies which reach implantation are minor, this could be because only the most robust embryos are able to get this far. The objectives of embryo-related research should be to improve culture conditions to the point where IVF pregnancy losses are reduced to the rates seen following in-vivo conception. Improvements of this nature may have the added benefit of increasing implantation rate per embryo. There is some evidence from our natural cycle IVF pro¬ gramme that such changes are already beginning to take place, because the percentage of clinical pregnancies which have resulted in a normal-term delivery has increased from 59% in 1987 to 62%, in 1988, 67% in 1989 and 83% in 1990 . The 1990 figure of 83% is not much lower than the target in-vivo figure of 88%, but, despite this steady amelioration in pregnancy wastage, significant improvements in implantation rates per embryo have not yet been achieved.
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